Penumbra Impresses With Market Share Gains in Computer-Assisted Thrombectomy - Stock Reaches new Annual High!

Penumbra (PEN) has established itself as a medical technology company specializing in the minimally invasive treatment of neurovascular and peripheral vascular diseases. The US market accounts for 77% of revenues, where nine new products were launched last year alone. In particular, CAVT systems (Computer Assisted Vacuum Thrombectomy) can help capture additional market shares. Blood clots are drawn into a catheter via vacuum and are quickly and effectively aspirated with the aid of computer support. CEO Adam Elsesser recently asserted confidently,...